Company Receives NIH Grant for Novel Investigational Antibiotic to Combat "Super Gonorrhea"
May 27th 2025TAXIS Pharmaceuticals announced it received a $2.9 million federal grant, which will allow the company to further advance its efforts with its dihydrofolate reductase inhibitors for the rapidly spreading and antibiotic-resistant strain of Neisseria gonorrhoeae.
Clinicians Discuss the State of Vaccines Today
A panel discusses how vaccine policy under new federal government policies, why misinformation has flourished and what individual providers can do to win back patient trust.
Persistent Strain of E coli That Caused Multiple Outbreaks Identified
May 17th 2025A Centers for Disease Control and Prevention (CDC) publication reports on REPEXH01, a strain of Shiga toxin–producing Escherichia coli (STEC) O157:H7, which has been responsible for at least 9 outbreaks in the US since 2017.
Can Diagnostics Aid in Alleviating Antimicrobial Resistance and Sepsis?
May 16th 2025In our latest From Pathogen to Infectious Disease Diagnosis podcast, bioMérieux Chief Medical Officer Chuck Cooper, MD, discusses the burden of resistance, and insights on the company’s novel Vitek Compact Pro ID/AST system, which looks to identify infectious disease in a timely manner, and aid clinicians in diagnosing patients and streamlining antimicrobial treatment and avoiding severe complications such as sepsis.